Vitamin B12, Vitamin C, Vitamin B6, Vitamin E and Riboflavin: study protocols
7 study groups took Vitamin B12 together with Vitamin C, Vitamin B6, Vitamin E and Riboflavin. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin B12
7 study groups in 6 studies say how much Vitamin B12 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2.5 mcg to 5 mcg and 25 mcg to 50 mcg, 29% of 7 study groups each.
| Daily dose | Study groups |
|---|---|
| 1 mcg to 2.5 mcg | 1 |
| 2.5 mcg to 5 mcg | 2 |
| 5 mcg to 10 mcg | 1 |
| 10 mcg to 25 mcg | 0 |
| 25 mcg to 50 mcg | 2 |
| 50 mcg to 100 mcg | 0 |
| 100 mcg to 250 mcg | 0 |
| 250 mcg to 500 mcg | 1 |
Dose per serving from research: Vitamin C
6 study groups in 5 studies say how much Vitamin C participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mg to 500 mg, 50% of 6 study groups.
| Daily dose | Study groups |
|---|---|
| 50 mg or less | 1 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 1 |
| 250 mg to 500 mg | 3 |
Dose per serving from research: Vitamin B6
7 study groups in 6 studies say how much Vitamin B6 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg, 43% of 7 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mg to 2.5 mg | 3 |
| 2.5 mg to 5 mg | 0 |
| 5 mg to 10 mg | 1 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 1 |
Dose per serving from research: Vitamin E
6 study groups in 5 studies say how much Vitamin E participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 5 mg to 10 mg, 50% of 6 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg to 10 mg | 3 |
| 10 mg to 25 mg | 0 |
| 25 mg to 50 mg | 2 |
| 50 mg to 100 mg | 1 |
Dose per serving from research: Riboflavin
7 study groups in 6 studies say how much Riboflavin participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg, 43% of 7 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mg to 2.5 mg | 3 |
| 2.5 mg to 5 mg | 1 |
| 5 mg to 10 mg | 1 |
| 10 mg to 25 mg | 2 |
Commonly used together
7 of 7 study groups took Vitamin B12, Vitamin C, Vitamin B6, Vitamin E and Riboflavin with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Folic Acid | 6 |
| Thiamine | 6 |
| Vitamin A | 4 |
| Zinc | 4 |
| Copper | 3 |
| Iron | 3 |
| Niacin | 3 |
| Vitamin D | 3 |
7 study groups
| Study | |||||||
|---|---|---|---|---|---|---|---|
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 2 mcg | 50 mg | 1.7 mg | 8 mg | 1.6 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 2.6 mcg | 100 mg | 2.2 mg | 10 mg | 1.8 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 50 mcg | 500 mg | 25 mg | 30 mg | 20 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women | 50 mcg | 500 mg | 25 mg | 30 mg | 20 mg | — | — |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 10 mcg | 200 mg | 10 mg | 100 mg | 10 mg | 120 days | — |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 400 mcg | 500 mg | 50 mg | 800 IU | 5 mg | 2 weeks | 24 |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 2.6 mcg | — | 1.9 mg | 10 mg | 1.4 mg | 12 weeks | 105 |